10 Leading tirzepatide Suppliers in China 2026

Introduction to Tirzepatide

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It has shown remarkable efficacy in the treatment of type 2 diabetes and obesity. By targeting both GIP and GLP - 1 receptors, tirzepatide can enhance insulin secretion, suppress glucagon secretion, slow gastric emptying, and reduce food intake, resulting in better glycemic control and significant weight loss. With its unique mechanism of action and promising clinical results, tirzepatide has attracted wide attention in the global pharmaceutical market, and China has emerged as an important source of tirzepatide suppliers.

1. Guangzhou Yonsci Bio-Technology Co., Ltd.

Company Introduction

Guangzhou Yonsci Bio-Technology Co., Ltd. is a leading biotech firm that specializes in the research, development, and production of high - quality raw materials for the pharmaceutical industry. The company is committed to providing innovative and reliable products to meet the diverse needs of its customers worldwide. Yonsci Biotechnology has a state - of - the - art R & D center and production facilities, staffed by a team of experienced scientists and technicians. They adhere to strict quality control standards throughout the production process, ensuring the purity and stability of their tirzepatide products.

Tirzepatide - related Features and Advantages

• High - Quality Products: Yonsci Biotechnology uses advanced production techniques and strict quality control measures to ensure that its tirzepatide has high purity. The company conducts multiple rounds of purification and testing to meet the international quality standards, which makes its products highly competitive in the global market.
• Customized Solutions: Recognizing the different requirements of customers, Yonsci Biotechnology offers customized tirzepatide products. Whether it is the dosage form, packaging, or specific quality parameters, the company can work closely with customers to develop tailored solutions.
• Strong R & D Capability: The company invests heavily in research and development. Its R & D team is constantly exploring new production processes and improving the quality of tirzepatide. This enables Yonsci Biotechnology to stay at the forefront of the industry and quickly adapt to market changes.
• Global Reach: Yonsci Biotechnology has established a wide - reaching sales network around the world. Through effective marketing strategies and excellent customer service, the company has successfully exported its tirzepatide products to many countries and regions, building a good reputation in the international market.
• Website: https://www.Guangzhou Yonsci Bio-Technology Co., Ltd..com/

2. Shanghai Henlius Biotech, Inc.

Company Introduction

Shanghai Henlius Biotech, Inc. is a well - known biopharmaceutical company in China. It has a comprehensive R & D and production platform covering monoclonal antibodies, fusion proteins, and other biopharmaceutical products. The company is dedicated to developing innovative drugs to address unmet medical needs. With a large - scale production base and a professional R & D team, Shanghai Henlius Biotech has the ability to produce tirzepatide on a large scale.

Tirzepatide - related Features and Advantages

• Integrated R & D and Production: Shanghai Henlius Biotech has an integrated R & D and production system. From the initial research on the mechanism of tirzepatide to the large - scale production, the company can complete all the processes independently. This not only ensures the quality and supply stability of tirzepatide but also reduces production costs.
• Quality Assurance System: The company has established a strict quality assurance system in accordance with international standards. Every batch of tirzepatide products undergoes multiple quality inspections, including raw material testing, in - process monitoring, and finished - product testing. This ensures that the products meet the highest quality requirements.
• Clinical Development Experience: Shanghai Henlius Biotech has rich experience in clinical development. It has carried out a series of clinical trials for tirzepatide, which helps to better understand the efficacy and safety of the product. This experience also enables the company to optimize the production process and product quality based on clinical feedback.
• Talent Pool: The company has attracted a large number of high - level professionals in the fields of biology, pharmacy, and medicine. These talents contribute to the continuous innovation and development of tirzepatide products, ensuring that the company can maintain its leading position in the industry.

3. WuXi Biologics (Cayman) Inc.

Company Introduction

WuXi Biologics (Cayman) Inc. is a global leading open - access biologics technology platform company. It provides end - to - end solutions for biologics discovery, development, and manufacturing. With a large - scale manufacturing capacity and advanced technology platform, WuXi Biologics can support the production of tirzepatide from pre - clinical research to commercial production.

Tirzepatide - related Features and Advantages

• Global - scale Manufacturing Capacity: WuXi Biologics has large - scale manufacturing facilities around the world. This allows it to produce tirzepatide in large quantities to meet the growing market demand. The company's manufacturing processes are highly automated and standardized, ensuring high - quality and efficient production.
• Advanced Technology Platform: The company has developed a series of advanced technology platforms, such as high - throughput screening technology and cell line development technology. These technologies can be applied to the research and development of tirzepatide, accelerating the product development process and improving product quality.
• Regulatory Compliance: WuXi Biologics has extensive experience in regulatory compliance. It can ensure that the production and sales of tirzepatide products comply with the regulations of different countries and regions. This is crucial for the global marketing of tirzepatide products.
• Collaboration Ecosystem: The company has established a wide - ranging collaboration ecosystem with many pharmaceutical companies, research institutions, and universities. Through these collaborations, WuXi Biologics can access more resources and knowledge, which is beneficial for the continuous improvement of tirzepatide products.

4. Innovent Biologics, Inc.

Company Introduction

Innovent Biologics, Inc. is a biopharmaceutical company focused on the research, development, production, and commercialization of innovative biologics. The company has a strong R & D team and a modern production base. It is committed to developing high - quality drugs to improve the health of patients. In the field of tirzepatide, Innovent Biologics has carried out in - depth research and development work.

Tirzepatide - related Features and Advantages

• Innovative R & D Concept: Innovent Biologics adheres to an innovative R & D concept. It combines the latest scientific research results with clinical needs to develop tirzepatide products with unique advantages. For example, the company is exploring new drug delivery systems for tirzepatide to improve its bioavailability and patient compliance.
• Patient - centered Approach: The company always puts patients at the center of its work. When developing tirzepatide, it takes into account the needs and experiences of patients. This includes improving the convenience of drug use, reducing side effects, and providing better patient support services.
• Quality - driven Production: Innovent Biologics emphasizes quality - driven production. It uses advanced quality control methods and strict production management systems to ensure the stability and consistency of tirzepatide products. This helps to build a good brand image and gain the trust of customers.
• Market - oriented Strategy: The company formulates market - oriented strategies based on the market demand and competition situation. It actively promotes the clinical application and market penetration of tirzepatide products, aiming to make its products widely available to patients in need.

5. BeiGene, Ltd.

Company Introduction

BeiGene, Ltd. is a global, commercial - stage biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative medicines. It has a comprehensive R & D and commercialization platform. BeiGene has a strong interest in the field of metabolic diseases, and tirzepatide is one of the important products in its R & D pipeline.

Tirzepatide - related Features and Advantages

• Global R & D and Commercialization Network: BeiGene has established a global R & D and commercialization network. This allows it to conduct multi - center clinical trials for tirzepatide in different regions and quickly bring the products to the global market. The company's global presence also helps it to better understand the market needs and regulatory requirements of different countries.
• Data - driven Decision - making: BeiGene uses data - driven decision - making in the R & D and production of tirzepatide. It collects and analyzes a large amount of data from pre - clinical research, clinical trials, and market feedback. Based on this data, the company can optimize the product development process, improve product quality, and make more informed marketing decisions.
• Talent and Innovation Culture: The company has a strong talent pool and an innovation - friendly culture. It encourages employees to think creatively and take risks in the R & D of tirzepatide. This culture promotes continuous innovation and the development of high - quality products.
• Partnerships and Alliances: BeiGene has established partnerships and alliances with many international pharmaceutical companies and research institutions. Through these collaborations, the company can access more resources and expertise, which is beneficial for the research and development of tirzepatide.

6. Zai Lab Limited

Company Introduction

Zai Lab Limited is a biopharmaceutical company focused on bringing innovative medicines to patients in China and around the world. It has a diversified product portfolio and a strong R & D team. Zai Lab is actively involved in the research and development of tirzepatide, aiming to provide effective treatment options for patients with type 2 diabetes and obesity.

Tirzepatide - related Features and Advantages

• Diversified R & D Pipeline: Zai Lab has a diversified R & D pipeline, which includes not only tirzepatide but also other drugs for metabolic diseases and other therapeutic areas. This diversification helps to reduce the R & D risk and provides more opportunities for product innovation.
• Market - access Expertise: The company has rich experience in market access. It understands the market environment and regulatory policies in different regions, which enables it to quickly and effectively promote the commercialization of tirzepatide products.
• Patient - education Initiatives: Zai Lab is committed to patient - education initiatives. It provides patients with information about tirzepatide, including its efficacy, safety, and usage methods. This helps to improve patient awareness and compliance, which is beneficial for the clinical application of tirzepatide.
• Technology Transfer and Licensing: Zai Lab actively engages in technology transfer and licensing activities. It can introduce advanced technologies and R & D achievements from abroad and combine them with its own R & D capabilities to accelerate the development of tirzepatide products.

7. CStone Pharmaceuticals Co., Ltd.

Company Introduction

CStone Pharmaceuticals Co., Ltd. is a biopharmaceutical company dedicated to developing and commercializing innovative oncology and other therapeutic drugs. Although it is mainly known for oncology drugs, the company has also extended its R & D scope to metabolic diseases, including tirzepatide. It has a professional R & D team and a modern production facility.

Tirzepatide - related Features and Advantages

• Cross - disciplinary R & D Approach: CStone Pharmaceuticals uses a cross - disciplinary R & D approach in the development of tirzepatide. It combines the knowledge and technologies from oncology research, such as drug delivery systems and immunotherapy concepts, with the characteristics of metabolic diseases. This innovative approach may bring new breakthroughs in the treatment of type 2 diabetes and obesity.
• Quality - control in Production: The company has strict quality - control measures in the production of tirzepatide. It follows the highest industry standards to ensure the purity, stability, and safety of the products. This high - quality production ensures that the products can meet the requirements of both domestic and international markets.
• Clinical - trial Design and Execution: CStone Pharmaceuticals has rich experience in clinical - trial design and execution. It can design scientific and reasonable clinical trials for tirzepatide, which helps to accurately evaluate the efficacy and safety of the product. The company also has a good track record in coordinating multi - center clinical trials, ensuring the smooth progress of the research.
• Long - term Vision for Product Development: The company has a long - term vision for the development of tirzepatide. It plans to continuously improve the product based on market feedback and scientific research results, aiming to make tirzepatide a leading product in the treatment of metabolic diseases.

8. Genor Biopharma Co., Ltd.

Company Introduction

Genor Biopharma Co., Ltd. is a biopharmaceutical company focusing on the research, development, and production of biologics. It has a state - of - the - art R & D center and a large - scale production base. The company is committed to developing high - quality drugs to meet the medical needs of patients. In the field of tirzepatide, Genor Biopharma has made significant progress in R & D and production.

Tirzepatide - related Features and Advantages

• Advanced Production Technology: Genor Biopharma uses advanced production technology for tirzepatide. It has developed a unique fermentation and purification process, which can improve the yield and quality of tirzepatide. This advanced technology gives the company a competitive advantage in the market.
• Intellectual Property Protection: The company attaches great importance to intellectual property protection. It has applied for a series of patents related to tirzepatide, including production processes, formulations, and new applications. These patents not only protect the company's R & D achievements but also enhance its market competitiveness.
• Customer - focused Service: Genor Biopharma provides customer - focused service. It maintains close communication with customers, understands their needs, and provides timely and effective solutions. This good service attitude helps to build long - term partnerships with customers.
• Continuous Innovation in R & D: The company has a strong R & D team that is constantly exploring new ideas and technologies for tirzepatide. It invests a large amount of resources in R & D to ensure the continuous innovation and improvement of the product.

9. Ascletis Pharma Inc.

Company Introduction

Ascletis Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and commercialization of innovative drugs. It has a wide - ranging R & D portfolio covering various therapeutic areas, including metabolic diseases. Ascletis Pharma is actively involved in the development of tirzepatide, aiming to provide better treatment options for patients.

Tirzepatide - related Features and Advantages

• Integrated R & D and Commercialization Model: Ascletis Pharma has an integrated R & D and commercialization model. It can independently complete the entire process from tirzepatide R & D to market launch. This model allows the company to have better control over the product life cycle and quickly respond to market changes.
• Data - analytics in R & D: The company uses data - analytics in the R & D of tirzepatide. By analyzing a large amount of data from pre - clinical research, clinical trials, and market data, Ascletis Pharma can make more accurate decisions in product development, such as optimizing the dosage form and treatment regimen.
• Regulatory - compliance Expertise: Ascletis Pharma has in - depth knowledge of regulatory compliance. It can ensure that the development and production of tirzepatide products comply with the regulations of different countries and regions. This expertise is crucial for the global marketing of the products.
• Strategic Partnerships: The company has established strategic partnerships with many domestic and international pharmaceutical companies and research institutions. Through these partnerships, Ascletis Pharma can access more resources and technologies, which is beneficial for the research and development of tirzepatide.

10. I-Mab Biopharma Inc.

Company Introduction

I - Mab Biopharma Inc. is a clinical - stage biopharmaceutical company focused on discovering and developing novel biologics. It has a strong R & D team and a unique R & D platform. The company is exploring the potential of tirzepatide in the treatment of metabolic diseases and is committed to bringing innovative products to the market.

Tirzepatide - related Features and Advantages

• Novel R & D Platform: I - Mab Biopharma has a novel R & D platform that can be used for the rapid discovery and development of tirzepatide. This platform combines advanced technologies such as artificial intelligence and high - throughput screening, which can accelerate the R & D process and improve the success rate of product development.
• Targeted R & D Strategy: The company adopts a targeted R & D strategy for tirzepatide. It focuses on specific patient populations and unmet medical needs, aiming to develop more effective and personalized treatment options. This targeted approach can increase the clinical value of the product.
• International R & D Collaboration: I - Mab Biopharma actively participates in international R & D collaborations. It cooperates with international research institutions and pharmaceutical companies to share knowledge and resources. This international cooperation helps the company to keep up with the latest international research trends and improve the quality of its tirzepatide products.
• Flexible R & D and Production Model: The company has a flexible R & D and production model. It can adjust the R & D and production plans according to market demand and scientific research progress. This flexibility enables the company to quickly respond to changes in the market and ensure the timely supply of tirzepatide products.

Conclusion

The 10 leading tirzepatide suppliers in China in 2026, including Guangzhou Yonsci Bio-Technology Co., Ltd., Shanghai Henlius Biotech, Inc., and others, all play important roles in the development and production of tirzepatide. These companies have their own unique features and advantages, such as strong R & D capabilities, high - quality production, and global market reach. With the continuous development of the biopharmaceutical industry and the increasing demand for tirzepatide, these suppliers are expected to further improve their products and services, and contribute to the treatment of type 2 diabetes and obesity on a global scale. Their efforts will not only bring benefits to patients but also promote the development of the entire biopharmaceutical industry in China and around the world.